Synthesis, biological evaluation, and molecular docking of N'-(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

A series of new N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazide derivatives were synthesized. Starting from ethyl piperidine-4-carboxylate (a), first ethyl 1-(phenylsulfonyl)piperidine-4-carboxylate (1), second 1-(phenylsulfonyl)piperidine-4-carbohydrazide (2), and finally N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazides (4a--n) were synthesized by reacting 2 with alkyl/aryl sulfonyl chlorides (3a--n). The structures of the synthesized compounds were characterized by IR, 1H-NMR, and EI-MS spectra and all were screened in vitro for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme inhibition activities. Molecular docking was accomplished for these compounds to examine their binding interactions with AChE and BChE human proteins. The strategy we applied for this purpose was a direct receptor-based approach. The binding modes of the inhibitors under study were determined using an automated docking program (AutoDock) and were compared with antienzymatic IC50 values. Both studies confirmed the potential of compounds as excellent inhibitors for AChE and BChE.

Synthesis, biological evaluation, and molecular docking of N′ -(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

A series of new N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazide derivatives were synthesized. Starting from ethyl piperidine-4-carboxylate (a), first ethyl 1-(phenylsulfonyl)piperidine-4-carboxylate (1), second 1-(phenylsulfonyl)piperidine-4-carbohydrazide (2), and finally N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazides (4a--n) were synthesized by reacting 2 with alkyl/aryl sulfonyl chlorides (3a--n). The structures of the synthesized compounds were characterized by IR, 1H-NMR, and EI-MS spectra and all were screened in vitro for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme inhibition activities. Molecular docking was accomplished for these compounds to examine their binding interactions with AChE and BChE human proteins. The strategy we applied for this purpose was a direct receptor-based approach. The binding modes of the inhibitors under study were determined using an automated docking program (AutoDock) and were compared with antienzymatic IC50 values. Both studies confirmed the potential of compounds as excellent inhibitors for AChE and BChE.

___

  • Massoulie, J.; Pezzementi, L.; Bon, S.; Krejci, E.; Valette, F. M. Prog. Neurobiol. 1993, 41, 31–91.
  • Chatonnet, A.; Lockridge, O. Biochem. J. 1989, 260, 625–634.
  • C ¸ oku˘ gra¸s, N. A. Turk. J. Biochem. 2003, 28, 54–61.
  • Sussman, L. J.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Protein Sci. 1991, 253, 872–878.
  • Gilman, A. G.; Rall, T. W.; Nies, A.; Taylor, P. In The Pharmacological Basis of Therapeutics; Eds. Pergamon, New York 1990, pp. 131–149.
  • Hallak, M.; Giacobini, E. Neuropharmacology 1989, 28, 199–206.
  • Scarpini, E.; Scheltens, P.; Feldman, H. Lancet Neurol. 2003, 2, 539–547.
  • Perry, E. K.; Tomlinson, B. E.; Blessed, G.; Bergman, K.; Gibson, P. H.; Perry, R. H. Brit. Med. J. 1978, 25, 1457–1459.
  • Holzgrabe, U.; Kapkova, P.; Alptuzun, V.; Scheiber, J.; Kugelmann, E. Expert. Opin. Ther. Targets 2007, 11, 161–179.
  • Butini, S.; Campiani, G.; Borriello, M.; Gemma, S.; Panico, A.; Persico, M.; Catalanotti, B.; Ros, S.; Brindisi, M.; Agnusdei, M.; et al. J. Med. Chem. 2008, 51, 3154–3170.
  • Bartolini, M.; Bertucci, C.; Cavrini, V.; Andrisano, V. Biochem. Pharmacol. 2003, 65, 407–416.
  • Shafferman, A.; Velan, B.; Ordentlich, A.; Kronman, C.; Grosfeld, H.; Leitner, M.; Flashner, Y.; Cohen, S.; Barak, D.; Ariel, N. EMBO J. 1992, 11, 3561–3568.
  • Changeux, J. P. Mol. Pharmacol. 1966, 2, 369–392.
  • Cochard, P.; Coltey, P. Dev. Biol. 1983, 98, 221–238.
  • Chatonnet, A.; Lockridge, O. Biochem. J. 1989, 260, 625–634.
  • Sikorav, J. L.; Krejci, E.; Massoulie, J. EMBO J. 1987, 6, 1865–1873.
  • Solis, A.; Nava, A.; Perez, H. I.; Manjarrez, N.; Luna, H.; Cassani, J. J. Mex. Chem. Soc. 2008, 52, 181–184. Khalid, H. Aziz-ur-Rehman; Abbasi, M. A.; Khan, K. M. Int. J. Pharm. Pharm. Sci. 2012, 4, 443–448.
  • Aziz-ur-Rehman; Nafeesa, K.; Abbasi, M. A.; Khalid, H.; Khan, K. M.; Ashraf, M.; Ahmad, I.; Ejaz, S. A. Asian. J. Pharm. Hea. Sci. 2012, 2, 370–376.
  • Aziz-ur-Rehman; Siddiqui, S. Z.; Abbas, N.; Abbasi, M. A.; Khan, K. M.; Shahid, M.; Mahmood, Y.; Akhtar, N. M.; Lajis, N. H. Int. J. Pharm. Pharm. Sci. 2012, 4, 676–680.
  • Ellman, G. L.; Courtney, K. D.; Andres, V.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88–95.
  • Kryger, G.; Harel, M.; Giles, K.; Toker, L.; Velan, B.; Lazar, A.; Kronman, C.; Barak, D.; Ariel, N.; Shafferman, A.; et al. Acta. Crystallogr. D. 2000, 56, 1385–1394.
  • Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. J. Comput. Chem. 2004, 25, 1605–1612.
  • Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graphics 1996, 14, 33–38.
  • Allouche, A. R. J. Comput. Chem. 2010, 32, 174–182.
  • Stewart, J. P. J. Mol. Model. 2007, 13, 1173–1213.
  • Trott, O.; Olson, A. J. J. Comput. Chem. 2010, 31, 455–461.
  • Deng, X; Mani, N. S. Green Chem. 2006, 8, 835–838.
  • Jafarpour, M; Rezaeifard, A; Golshani, T. J. Phosphorous, Sulfur and Silicon. 2011, 186, 140–148.
  • Aziz-ur-Rehman; Afroz, S; Abbasi, M. A; Tanveer, W; Khan, K. M; Asraf, M; Afzal, I; Ambreen. Pak. J. Pharm. Sci. 2012, 25, 809–814.
  • Aziz-ur-Rehman; Rasool, S; Abbasi, M. A; Khan, K. M; Asraf, M.; Afzal, I. Asian J. Phram. Bio. Res. 2012, 2, 100–105.
  • Aziz-ur-Rehman; Awais-ur-Rehman; Abbasi, M. A; Khalid, H; Khan, K. M; Dar, P. Asian J. Pharm. Hea. Sci. 2012, 2, 384–389.
Turkish Journal of Chemistry-Cover
  • ISSN: 1300-0527
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Spectrophotometric determination of molybdenum using surfactant-mediated liquid liquid extraction

Rameshwar DASS, Jitander Kumar KAPOOR, Sunita GAMBHIR

Speciation of chromium by the combination of dispersive liquid--liquid microextraction and microsample injection flame atomic absorption spectrometry

Yunus Emre ÜNSAL, Mustafa TÜZEN, Mustafa SOYLAK

Calixpenams: synthesis, characterization, and biological evaluation of penicillins V and X clustered by calixarene scaffold

Fazel NASUHI PUR, Karim AKBARI DILMAGHANI

Optimization of LiFePO4 synthesis by hydrothermal method

Muhsin MAZMAN, Ömür ÇUHADAR, Davut UZUN, Ercan AVCI

Speciation of chromium by the combination of dispersive liquid liquid microextraction and microsample injection flame atomic absorption spectrometry

Mustafa TUZEN, Yunus Emre UNSAL, Mustafa SOYLAK

Synthesis of new pyrazole and antibacterial pyrazolopyrimidine derivatives

Ameur RAHMOUNI, Anis ROMDHANE, Abderrahim Ben SAID, Kaouther MAJOULI, Hichem BEN JANNET

Synthesis and characterization of new (E)-N'-(substituted benzylidene)-2-(3-(2- methyl)-4-oxo-3,4-dihydroquinazolin-2-ylthio)acetohydrazides

Ulrich FLORKE, Aamer SAEED, Shams-ul MAHMOOD

Synthesis and characterization of new metallophthalocyanines containing O4S2 mixed-donor substituted macrocyclic groups

Meltem Betül KILIÇASLAN, Halit KANTEKİN

Synthesis, biological evaluation, and molecular docking of ′ N -(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

Rashad HUSSAIN, Khalid MOHAMMAD KHAN, Muhammed ASHRAF, Syeda Abida EJAZ, Muhammad Qaiser FATMI, Hira KHALID, Aziz UR REHMAN, Muhammad Athar ABBASI

Effect of boric acid on corrosion and electrochemical performance of Pb-0.08% Ca-1.1% Sn alloys containing Cu, As, and Sb impurities for manufacture of grids of lead-acid batteries

Said SALIH, Ahmed GAD-ALLAH, Ashraf ABD EL-WAHAB, Hamid ABD EL-RAHMAN